Prostate Cancer Molecular Medicine (PCMM).
Recruiting
- Conditions
- Prostate cancer / prostaatkanker
- Registration Number
- NL-OMON27495
- Lead Sponsor
- Erasmus MC, NKI-AvL, UMCG, UMC
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
Group 1:
1. Planned to undergo prostate biopsies according to standard practice;
Exclusion Criteria
Group 1 and group 2:
1. Known allergy to contrast agents or sulphur hexafluoride micro bubbles;
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Construction of a Dutch multicenter prospective biorepository for validation of biomarker and imaging products.
- Secondary Outcome Measures
Name Time Method 1. Newly developed biomarkers and imaging tools that can improve the diagnosis, prognosis and therapy monitoring for prostate cancer;<br /><br>2. An IT infrastructure for the integration of the complex information from biomarker analysis and (molecular) imaging, next to individual clinical data and biobank data, allowing for the future development of a Clinical Decision Support System (CDSS) that optimizes clinical decision making.